Project Grant R21AI200773
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Johns Hopkins University a $145,299 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025 through July 31, 2029. This award supports the development of novel Bayesian causal structural discovery and reinforcement learning methods to advance precision medicine in HIV care, specifically addressing the challenge of designing...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Johns Hopkins University a $779,616 Project Grant effective April 10, 2026, through March 31, 2031, under the Allergy and Infectious Diseases Research program (CFDA 93.855). This research initiative focuses on characterizing the defective human immunodeficiency virus type 1 (HIV-1) proviral reservoir in children and young adults living with perinatal HIV-1 infection. The research will...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Johns Hopkins University a Project Grant of $427,438 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period April 1, 2026 through March 31, 2028. This research initiative focuses on identifying and eliminating antigen-specific expanded clones of latently infected CD4+ T cells as a strategy to reduce the size of the Human Immunodeficiency Virus (HIV)...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Johns Hopkins University a $696,200 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on May 12, 2026, with a completion date of April 30, 2031. The grant supports the ON-Demand HIV Prevention Across the Lifespan (OPAL) Study, which investigates the pharmacokinetics and pharmacodynamics of emtricitabine/tenofovir disoproxil fumarate (F/TDF) pre-exposure...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Johns Hopkins University a Project Grant of $247,125 under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective May 21, 2026 through April 30, 2028. This award supports the isolation and functional characterization of monoclonal antibodies (mAbs) directed against the HIV-1 antisense protein ASP (antisense protein) derived from people living with HIV-1 (PLWH),...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Johns Hopkins University a $672,248 Project Grant (CFDA 93.855 – Allergy and Infectious Diseases Research) on September 15, 2025, to conduct a comprehensive five-year research initiative examining HIV reservoir dynamics and immune responses across the female reproductive lifespan. Led by co-principal investigators Dr. Eileen Scully (Johns Hopkins University) and Dr. Ronald Galiwango (Rakai...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Johns Hopkins University a Project Grant of $765,422 (awarded April 17, 2026) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct systematic research on mechanisms of antigen diversification in Trypanosoma brucei. The research will be performed in Baltimore, Maryland, with an anticipated completion date of March 31, 2031. The project delivers...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Chicago a Project Grant of $126,435 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on September 16, 2025, with an ultimate completion date of August 31, 2030. The award supports the INFOHIV program, a patient-oriented research initiative focused on improving outcomes across HIV prevention and care continua through implementation of clinical informatics...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Johns Hopkins University a $426,625 Project Grant (CFDA 93.855, Allergy and Infectious Diseases Research) beginning August 7, 2025, and concluding July 31, 2027, to conduct quantitative assessment research on the Dual Path Platform (DPP) Syphilis TNT (Treponemal and Non-Treponemal) assay. The research addresses a significant public health need by evaluating the feasibility of using this...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Miriam Hospital a Project Grant of $200,824 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop and pilot SAI (STI Prevention AI-Chatbot), an artificial intelligence-powered intervention tool designed to promote doxycycline post-exposure prophylaxis (Doxy-PEP) uptake among men who have sex with men (MSM). The chatbot leverages the latest ChatGPT...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Johns Hopkins University a Project Grant totaling $426,823 (awarded June 3, 2026; completion May 31, 2028) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop and evaluate PRISM-HIV, an artificial intelligence-driven, case-based learning platform for continuing medical education in HIV medicine. The project extends prior work on PRISM (Precision Review and Interactive Simulation in Medicine), a large language model-based educational tool, by creating an interactive clinical learning system that simulates faculty-led case discussions and diagnostic feedback. PRISM-HIV is designed to deliver personalized, scalable medical education aligned with the Foundations in HIV Medicine curriculum and targets medical residents, general internists, and advanced practice providers who require enhanced training in HIV medicine to address the documented shortage of skilled HIV clinicians in the United States. The primary deliverable is a functional AI-powered educational platform that guides learners through interactive HIV case scenarios, promotes clinical reasoning development, provides precision-targeted review content, and assesses user performance. By leveraging large language model technology to simulate expert clinical instruction, PRISM-HIV addresses a critical gap in continuing medical education—scaling case-based and flipped-classroom learning approaches that traditionally require intensive faculty resources. The project directly supports the NIH's research objective to strengthen the HIV clinical workforce through innovative educational tools that improve clinician confidence and competency in HIV care management.Federal Project Grant Summary: PRIME-HIV
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $426.8k | 6/8/26 |